Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc A Pfeffer

Showing results (31-40 of 520) with videos related to

Pageof 52
Sort By:
Journal of the American College of Cardiology|November 11, 2003
Aldosterone antagonism and myocardial infarction: from animals to man and backScott D Solomon, Marc A Pfeffer
European Heart Journal|August 17, 2017
Beyond the P-value and the sound bite: learning from 'negative' clinical trialsAkshay S Desai, Marc A Pfeffer
European Heart Journal|June 6, 2014
Heart failure with preserved ejection fraction: a forest of a variety of treesAmil M Shah, Marc A Pfeffer
Circulation|June 22, 2016
The Future of Clinical Trials in Cardiovascular MedicineScott D Solomon, Marc A Pfeffer
Circulation|October 23, 2002
Renin-angiotensin system and cardiac rupture after myocardial infarctionScott D Solomon, Marc A Pfeffer
European Heart Journal|May 11, 2020
Plasma angiotensin-converting enzyme 2: novel biomarker in heart failure with implications for COVID-19Gavin Y Oudit, Marc A Pfeffer
American Heart Journal|May 17, 2005
Evaluation and management of patients with uncontrolled systolic hypertension: is another new paradigm really needed?Gary F Mitchell, Marc A Pfeffer
Kidney International. Supplement|October 16, 2004
Cardiovascular risk in chronic kidney diseaseNagesh S Anavekar, Marc A Pfeffer
American Journal of Physiology. Heart and Circulatory Physiology|July 11, 2006
Improvements in clinical outcomes with the use of angiotensin-converting enzyme inhibitors: cross-fertilization between clinical and basic investigationMarc A Pfeffer, Edward D Frohlich
The New England Journal of Medicine|October 4, 2018
COMMANDER HF - A Trial and an AnswerMarc A Pfeffer, Jean-Claude Tardif
Pageof 52

Showing results (31-40 of 520) with videos related to

Sort By:
Pageof 52
Journal of the American College of Cardiology|November 11, 2003
Aldosterone antagonism and myocardial infarction: from animals to man and backScott D Solomon, Marc A Pfeffer
European Heart Journal|August 17, 2017
Beyond the P-value and the sound bite: learning from 'negative' clinical trialsAkshay S Desai, Marc A Pfeffer
European Heart Journal|June 6, 2014
Heart failure with preserved ejection fraction: a forest of a variety of treesAmil M Shah, Marc A Pfeffer
Circulation|June 22, 2016
The Future of Clinical Trials in Cardiovascular MedicineScott D Solomon, Marc A Pfeffer
Circulation|October 23, 2002
Renin-angiotensin system and cardiac rupture after myocardial infarctionScott D Solomon, Marc A Pfeffer
European Heart Journal|May 11, 2020
Plasma angiotensin-converting enzyme 2: novel biomarker in heart failure with implications for COVID-19Gavin Y Oudit, Marc A Pfeffer
American Heart Journal|May 17, 2005
Evaluation and management of patients with uncontrolled systolic hypertension: is another new paradigm really needed?Gary F Mitchell, Marc A Pfeffer
Kidney International. Supplement|October 16, 2004
Cardiovascular risk in chronic kidney diseaseNagesh S Anavekar, Marc A Pfeffer
American Journal of Physiology. Heart and Circulatory Physiology|July 11, 2006
Improvements in clinical outcomes with the use of angiotensin-converting enzyme inhibitors: cross-fertilization between clinical and basic investigationMarc A Pfeffer, Edward D Frohlich
The New England Journal of Medicine|October 4, 2018
COMMANDER HF - A Trial and an AnswerMarc A Pfeffer, Jean-Claude Tardif
Pageof 52